# De-identified analysis of the expanded pain-point source

## Status and handling

- Source reviewed: owner-supplied `Oncologist Pain Points_v2.docx`.
- Review date: 2026-09-03.
- Extracted text reviewed completely: 344 lines.
- Raw-source status: private and ignored by Git.
- Publication rule: do not publish the raw document, exact participant narratives, quotations, dates, institutions, ages, diagnoses, family history, or care details.
- Evidence status: this analysis preserves only de-identified themes and source limitations.

The document materially expands the team's context, but it does not provide a new completed oncologist-workflow study. Most new empirical content consists of three informal caregiver accounts. Those accounts can generate hypotheses and contradict earlier assumptions; they cannot establish prevalence or justify a product by themselves.

## Document anatomy

| Section | Extracted lines | What it contains | Evidence treatment |
|---|---:|---|---|
| Original synthesis | 1–64 | The same oncologist pain-point summary already present in `Oncologist Pain Points.md` | Duplicate source; do not count as new confirmation |
| Proposed research material | 66–172 | Questionnaires, target-cohort ideas, proposed workflows, product heuristics, and assumed thresholds | Research plan or team hypothesis, not participant evidence |
| Caregiver narratives | 174–295 | Three informal accounts containing sensitive personal, family, institutional, diagnostic, temporal, and care details | Raw source remains private; retain only weak de-identified signals sharing one source group |
| General care-team primer | 296–344 | Broad descriptions of oncology roles and workflow without citations | Background hypothesis only; verify against primary sources before use |

The DOCX package contains document text, styles, numbering, embedded fonts, and repeated footer material. It contains no media, comments, headers, footnotes, or endnotes that add separate evidentiary content.

## What is genuinely new

### 1. Family and caregiver counselling may be a distinct coordination gap

Two of the three informal accounts describe family members receiving absent or inadequate counselling or psychosocial support while helping manage cancer care.

Safe interpretation:

- Family/caregiver support may be a separate service-access and coordination problem.
- The problem may involve identifying support, arranging access, clarifying responsibility, and providing clinician-approved general material.
- It must not be reduced to automated psychological advice or clinical assessment.

Evidence limit:

- Two informal accounts are not prevalence evidence.
- The accounts do not identify the responsible role, existing service, frequency, measurable burden, or preferred intervention.
- This warrants a new research hypothesis, not a promoted product candidate.

### 2. Cross-provider and cross-city care is more plausible than the earlier notes implied

The earlier informal discussion suggested that changing oncologists may be uncommon. The expanded source contains de-identified examples involving referrals, additional opinions, care across cities, and multiple providers.

Safe interpretation:

- The blanket assumption that oncology care usually remains with one doctor is not reliable.
- Record portability and reconciliation may matter during referral, additional-opinion, or multi-provider journeys.
- Candidate A—source-linked outside-record consultation readiness—gains weak supporting evidence as a fallback.

Evidence limit:

- These are selected narratives, not a measured rate of switching or referral.
- They do not identify the record preparer or total person-time.
- They do not prove that software, rather than policy or current interoperability, is the missing intervention.

### 3. Caregivers can perform substantial operational work

The informal accounts describe family members participating in record carrying, appointment coordination, navigation, communication, and care logistics.

Safe interpretation:

- The caregiver may be an important workflow participant or source of operational inputs.
- Caregiver-facing permissions, consent, communication, and record-boundary questions deserve explicit research.

Evidence limit:

- Do not generalise that a caregiver “almost always” manages the journey.
- The accounts do not establish a universal caregiver role or access entitlement.
- Professional care-team and patient authority must remain explicit.

### 4. Digital touchpoints can coexist with operational friction

Some accounts include digital booking, reminders, or retained records while also describing queues, coordination burden, or missing family support.

Safe interpretation:

- Presence of a digital feature is not evidence that the end-to-end job is complete.
- Measurement should use operational completion and burden, not feature availability or message delivery.

Evidence limit:

- The source provides no controlled comparison or timing baseline.
- Queueing and support gaps may have different causes and should not be collapsed into one feature request.

## Statements that must not become project facts

The expanded source contains several uncited or assumed statements. Retain them only as questions to verify:

- an unsourced `0.1%` statistic;
- public-hospital outpatient volumes above 100 patients per day as a general rule;
- the claim that a caregiver almost always manages operational care;
- the claim that corporate-hospital doctors generally have more time;
- the claim that residents or junior fellows are the primary chart-assembly user;
- a product interaction threshold greater than four minutes;
- causal claims connecting the home atmosphere to treatment response;
- “smart triage” or automatic identification of clinically at-risk patients.

The last item also risks prohibited clinical risk scoring or interpretation. A safe system may display human-assigned operational status; it must not infer clinical risk or urgency.

## Proposed questionnaires are not findings

The document contains useful questions for oncologists, caregivers, residents, nurses, and operations staff. Their presence does not mean:

- the questionnaires were administered;
- the listed cohort was recruited;
- the proposed sample distribution occurred;
- the described workflows were observed;
- the suggested time thresholds were measured;
- the proposed solution mappings were validated.

Before using questionnaire material as evidence, the internal analyst should clarify:

1. who wrote each section;
2. which sections summarise completed conversations;
3. how many oncologists or caregivers contributed;
4. participant specialties and settings;
5. whether notes were recorded contemporaneously;
6. whether the questionnaires were ever administered;
7. whether any answers exist separately;
8. which claims are direct statements versus the author's synthesis;
9. whether the three caregiver accounts were intentionally selected or are the full available sample;
10. whether a de-identified source ledger can be produced without publishing narratives.

## Delta against the current research

| Existing area | Change from V2 | Current disposition |
|---|---|---|
| Find | No new completed clinician evidence | Unchanged: supporting capability, weak India workload evidence |
| Contextualise | No new safe patient-specific evidence | Unchanged: record context is a design constraint; clinical contextualisation remains excluded |
| Synthesise | Weak additional signal for multi-provider records and caregiver record handling | Candidate A becomes a more credible fallback, but actor, frequency, and person-time remain open |
| Act | Proposed questions repeat clinically sensitive needs | Unchanged: patient-specific Act lane remains rejected |
| Connect | No answered tumour-board workflow detail | Owner-selected P5 remains open; V2 does not validate or overturn it |
| Follow-up/continuity | Caregiver and multi-provider accounts add weak context | Retain; do not convert selected narratives into prevalence |
| Clinic flow | Digital booking and queues coexist in selected accounts | Keep as an open hypothesis; no baseline or causal mechanism |
| Caregiver/family support | New repeated informal signal | Add a research lane for counselling and psychosocial-support coordination; not yet a candidate |
| Record portability | Cross-city and additional-opinion journeys weaken rare-switching assumption | Strengthen contradiction and fallback research for Candidate A |
| Resident/junior workflow | Role asserted in proposed material | Keep as an unevidenced role hypothesis until direct workflow evidence exists |

## Effect on Candidate B and P5

The expanded source contains no completed oncologist or operator account of tumour-board documentation, acknowledgement, ownership, or follow-through.

Therefore it does not justify:

- closing `P5`;
- abandoning Candidate B;
- sending external outreach immediately;
- beginning product architecture.

It does change the order of validation:

1. pause the external NCG/ECHO outreach;
2. ask the internal analyst to clarify the document's provenance, method, and whether questionnaire answers exist;
3. ask whether her clinician conversations contain direct evidence about tumour-board post-decision workflow;
4. test the new caregiver-support, multi-provider portability, resident/junior, and clinic-flow hypotheses;
5. resume external operator outreach only if the internal evidence cannot close the gap.

## New research questions

### Caregiver and family support

- In which settings are families offered counselling or psychosocial support?
- Who identifies the need, explains the service, and coordinates access?
- Which part is clinical assessment versus operational service navigation?
- How often do caregivers perform record, scheduling, travel, and communication work?
- What permissions and consent boundaries apply?
- What measurable operational result would improve?

### Multi-provider records and additional opinions

- How often do referrals, additional opinions, or cross-city care require history reconstruction?
- Who prepares the packet?
- Which original artifacts must travel?
- Which sources are repeated or re-verified?
- How much total staff and caregiver time is involved?
- What existing ABDM, EMR, portal, or paper workflow already supports it?

### Resident or junior-fellow workflow

- Does this role actually assemble histories or summaries in the target setting?
- For which consultations?
- Which artifacts and systems are used?
- Who verifies the work?
- What is the frequency and person-time?
- Would a tool remove work or add another review step?

### Clinic flow

- Where exactly does delay occur: registration, records, investigation, clinician queue, treatment day, billing, or discharge?
- Is the bottleneck capacity, scheduling, missing information, policy, or software?
- Which role owns it?
- Does digital booking alter waiting or only the booking channel?
- Which operational baseline is available?

## Evidence and privacy decision

- The raw DOCX remains local and ignored.
- Public artifacts may describe only de-identified themes, sample count, method limitations, and research implications.
- No exact narrative, quotation, age, date, institution, diagnosis, treatment history, family relationship, or location combination is published.
- All retained ledger records from the caregiver narratives share one independent source group so they cannot be counted as independent confirmation.
- Unsupported author assertions remain in this analysis only as rejected assumptions or research questions.

## Decision

The expanded source changes the research plan but not the selected product state:

- **Pause external outreach.** Ask the internal analyst about provenance and any completed answers first.
- **Retain P5 as current.** The document does not answer the tumour-board operator question.
- **Add caregiver/family psychosocial-support coordination as a new hypothesis.** Do not promote it yet.
- **Strengthen Candidate A as the first fallback.** Multi-provider and additional-opinion journeys are now harder to dismiss, but still lack an actor/time baseline.
- **Reject unsupported numerical, causal, user-role, and clinical-risk claims.**
- **Continue to require direct or attributable workflow evidence before architecture.**
